US Regulators Extend UDI Deadlines Following Security Issue

According to an announcement from Emergo, “Citing security vulnerabilities, the US Food and Drug Administration has extended deadlines for compliance with a key component of the agency’s Unique Device Identification (UDI) system.”  For more information on...

ICYMI: FDA Approves OxyContin for Pain in Kids 11 to 16

It was recently reported that “The Food and Drug Administration (FDA) on Thursday approved the powerful painkiller OxyContin for a new use in children 11 to 16 who are suffering from severe, long-term pain” according to the Seattle Times.  For more...

Patient Advocacy on Social Media: #q1advocacy

Miss out on the 4th Annual Strengthening Patient Advocacy Relations Conference? Take a look at some of the highlights from delegates, sponsors, and speakers on social media![View the story “Social Media Highlights from the 4th Annual Strengthening Patient...

ICYMI: Could These Devices Someday Replace Drugs?

MDDIonline.com recently released an article outlining the latest devices that may someday overtake pharmaceutical drugs.  “The U.S. pharmaceutical market is roughly double the size of that for medical devices. Perhaps sensing an opportunity, some device firms...

Eli Lilly Reports Medication Slows Alzheimer’s Decline

According to an article via South Bend Tribune, “Eli Lilly & Co. reported Wednesday that an experimental medication might slow mild Alzheimer’s if people take it early enough, one of a handful of drugs in late-stage testing in the frustrating hunt for a...